What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials

European Institute of Oncology100 enrolled

Overview

An observational prospective study of patients enrolled and treated with experimental drugs in Phase I studies.

The study focuses on defining the problem of geographical accessibility of patients to the Phase 1 facility of the European Institute of Oncology, based on an anonymized extraction of data from the enrolled patient database, to assess national territorial disparities in access to innovative experimental therapies, in relation to various socioeconomic determinants. Finally, information on relevant psychological factors for participation in clinical trials will also be collected.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Solid Tumor

Interventions

Solid TumorOTHER

The study focuses on defining the problem of geographical accessibility of patients to the Phase 1 facility of the European Institute of Oncology, based on anonymized data extraction from the enrolled patient database, to evaluate national territorial disparities in access to innovative experimental therapies, in relation to various socioeconomic determinants. Finally, relevant information on psychological factors for participation in clinical trials will also be collected.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria : * Patient with a histological or cytological diagnosis of solid or hematological tumor. * Age ≥ 18 years. * Patient enrolled in a phase 1 and early phase 2 study at our institution. * The patient has received at least 1 administration of the experimental drug under study in the early phase trial. Exclusion Criteria : \- Patients treated in phase 1 trials at other institutions, even if referred to our division or receiving standard therapies at IEO but outside of clinical trials, are not included.

Locations (1)

European Institute of oncology

Milan, Italy

RECRUITING

Outcomes

Primary Outcomes

The geographical accessibility of patients attending the Phase 1 facility of the European Institute of Oncology (IEO).

The primary endpoint is estimating the geographical distance from the enrolled patients' residences to the European Institute of Oncology (IEO), evaluating patients from the Lombardy region versus those from other regions with an assessment by geographical cluster: north, central, south, and islands, in order to define any preferential trajectories or recurring patterns.

Time frame: 1 year

Secondary Outcomes

The characterization of enrolled patients involves assessing their participation in clinical trials

The enrolled patients will be characterized based on psychological factors included in the study. These factors include: patient attitudes, perceived social norms, and perceived control over participation in clinical studies; doctor-patient relationship; study awareness; evaluation of their own decision to participate in the study

Time frame: 1 year

The characterization of enrolled patients based on therapeutic compliance.

The evaluation of compliance with protocol procedures unrelated to the administration of the experimental drug, such as pharmacokinetic sampling and study biopsies

Time frame: 1 year

The protocol prescriptions in relation to socioeconomic and geographical determinants.

The correlations with metrics of geographic accessibility and income per area of origin will be explored in accordance with ISTAT (Italian National Statistics Institute) data, where applicable.

Time frame: 1 year

Central Contacts

Teresa Profeta

CONTACT

+390294372561 teresa.profeta@ieo.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.